• Publications
  • Influence
Increases in heart rate variability with successful treatment in patients with major depressive disorder.
Findings indicate that pharmacologic treatment leading to improvement in MDD is associated with increased HRV, and brief measures of HRV could be developed as a useful adjunctive, physiologic measure of treatment response to pharmacotherapy in clinical trials and other settings.
Event-related potential amplitude/intensity slopes predict response to antidepressants.
The conclusion that P2 amplitude/intensity slope may be a predictor of response to treatment with antidepressant medication with patients diagnosed with major depressive disorder is supported.
Amplitude/intensity functions of auditory event-related potentials predict responsiveness to bupropion in major depressive disorder.
Results further support the previous finding that ERP amplitude/intensity functions measured under a stimulus intensity modulation paradigm provide information about the likelihood of a positive therapeutic response to antidepressant pharmacotherapy in patients with MDD and extends these results to bupropion, a pharmacologically atypical antidepressant agent.
Treatment of fluoxetine-induced anorgasmia with amantadine.
Fluoxetine differentially suppresses sucrose solution consumption in free-fed and food-deprived rats--reversal by amantadine.
Acute fluoxetine administration produces a reduction in palatable substance intake that is decreased in potency with a longer treatment-test interval, an effect likely not related to pharmacokinetic considerations.
Cardiovascular Changes Associated With Sexual Arousal and Orgasm in Men
Indices of cardiovascular function were measured in seven men while they masturbated to ejaculation. Cardiac electrical activity, respiration, finger pulse, and anal contractions were monitored.